Hypokalemic periodic paralysis: A case report and a topic review

Parálisis periódica hipocalémica: reporte de caso y revisión del tema

Article Sidebar


PDF (Español (España)) FLIP

How to Cite
Rojas García, W., Flórez Romero, A., & Pinzón Rincón, D. (2017). Hypokalemic periodic paralysis: A case report and a topic review. Journal of Medicine and Surgery Repertoire, 26(1), 35–38. Retrieved from https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/16
Published: Mar 1, 2017
Issue
Vol. 26 No. 1 (2017): Janaury - March
Section
Case Reports
License terms

   

Main Article Content

William Rojas García
Hospital de San José
Andrés Flórez Romero
Fundación Universitaria Ciencias de la Salud
Diana Pinzón Rincón
Fundación Universitaria Ciencias de la Salud

Abstract

Primary periodic paralyses are rare channelopathies which include: hypokalemic periodic paralysis, hyperkalemic periodic paralysis, and Andersen-Tawil Syndrome. These entities are characterized by attacks of generalized muscle weakness and recovery of muscle strength between attacks. A case is presented of a 21-year-old woman who presented a second episode of paralysis and documented hypokalemia, with no important antecedents, with no clinical or diagnostic test factors which explain her electrolyte disorder, with recovery of muscle strength after receiving treatment for hypokalemia. A review of the topic was conducted.

Keywords:

Downloads

Download data is not yet available.

Article Details

References

Statland J, Phillips L, Triverdi J. Muscle channelopathies. Neurol Clin. 2014;32:801–15.

Fontaine B. Periodic paralysis. Adv Genet. 2008;63:3–23.

Statland J, Barohn R. Muscle channelopathies: The nondystrophic myotonias and periodic paralyses. Continuum (Minneap Minn). 2014;19:1598–614.

Imbrici P, Liantonio A, Camerino G, de Bellis M, Camerino C, Mele A, et al. Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery. Front Pharmacol. 2016;7:121.

Ke T, Gomez CR, Mateus HE, Castano JA, Wang QK. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a South American family. J Hum Genet. 2009;54:60–4.

Zheng J, Liang Z, Hou Y, Liu F, Hu Y, Lin P, et al. A novel Kir2.6 mutation associated with hypokalemic periodic paralysis. Clin Nuerophysiol. 2016;127:2503–8.

Burge JA, Hanna MG. Novel insights into the pathomechanisms of eskeletal muscle channelopathies. Curr Neurol Neurosci Rep. 2012;12:62–9.

Lin SH, Lin YF, Chen DT, Chu P, Hsu CW, Halperin ML. Laboratory tests to determine the cause of hypokalemia and paralysis. Arch Intern Med. 2004;164:1561–6.

Sansone V, Meola G, Links T, Panzeri M, Rose MR. Treatment for periodic paralysis (Review). Cochrane Database Syst Rev. 2008:DC005045.

Bendahhou S, Cummins TR, Griggs RC, Fu YH, Ptacek LJ. Sodium channel inactivation defects are associated with acetazolamide-exacerbated hypokalemic periodic paralysis. Ann Neurol. 2001;50:417–20.

Sansone VA, Burge J, McDermott MP, Smith PC, Herr B, Tawil R, et al. Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. Neurology. 2016;86:1408–16.

Caciotti A, Morrone A, Domenici R, Donati MA, Zammarchi E. Severe prognosis in a large family with hypokalemic periodic paralysis. Muscle Nerve. 2003;27:165–9.

Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia. Muscle Nerve. 2004;30:114–7.

Citado por